Dr. Guido K. Frank, MD | San Diego, CA ...

Dr. Guido Frank, MD

Claim this profile

University of California San Diego

Studies Anorexia Nervosa
Studies Bulimia Nervosa
10 reported clinical trials
10 drugs studied

Affiliated Hospitals

Image of trial facility.
University Of California, San Diego
Image of trial facility.
University Of California At San Diego

Clinical Trials Guido Frank, MD is currently running

Image of trial facility.

Ketogenic Diet

for Anorexia

This study will investigate the effects of therapeutic ketogenic diet (TKD) on eating behavior including drive to restrict, body dissatisfaction, mood and anxiety in individuals with anorexia nervosa who have been weight normalized (body mass index of 17.5 or greater) but continue to struggle with eating disorder behaviors including a high drive for thinness and body dissatisfaction. The Underweight Anorexia Nervosa (AN) Sub-Study will investigate the effects of TKD on eating behavior including drive to restrict, body dissatisfaction, mood and anxiety in individuals with anorexia nervosa who are currently underweight (body mass index between 16.0 and 17.49) and continue to struggle with eating disorder behaviors including a high drive for thinness and body dissatisfaction. The Bulimia Nervosa Pilot will will investigate the effects of TKD on eating behavior including drive to binge and purge, body dissatisfaction, mood and anxiety in individuals with bulimia nervosa.
Recruiting1 award N/A
Image of trial facility.

Ketogenic Diet

for Anorexia Nervosa

This is a longitudinal study with an open design in weight recovered anorexia nervosa (wrAN) individuals. Healthy controls (HC) will also be assessed. Study participants will be carefully assessed and will have 18F-fluorodeoxyglucose (\[18F\]FDG) positron emission tomography (PET) scans for assessment of regional brain glucose uptake. The wrAN group will be compared to healthy controls. Participants in the wrAN group will then complete 14 weeks of therapeutic ketogenic diet (TKD). At the end of the TKD study, participants will have assessments and a second \[18F\]FDG and TMS/EEG scan. Study participants will be followed over six months after the intervention. This follow-up procedure will help determine whether symptom improvement will be stable or worsen in individuals who choose to continue or discontinue the TKD intervention. This will be a naturalistic follow-up.
Recruiting1 award N/A

More about Guido Frank, MD

Clinical Trial Related2 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Guido Frank, MD has experience with
  • Therapeutic Ketogenic Diet
  • Negative Affect Task
  • RTMS Treatment Using BrainsWay Model 104 System With H1-Coil
  • Sham TMS Using BrainsWay Model 104 System With H1-Coil
  • Kenetik Ketone Drink
  • Bromocriptine

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
What does Guido Frank, MD specialize in?
Is Guido Frank, MD currently recruiting for clinical trials?
Are there any treatments that Guido Frank, MD has studied deeply?
What is the best way to schedule an appointment with Guido Frank, MD?
What is the office address of Guido Frank, MD?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security